RT Journal Article
SR Electronic
T1 Biological Prognostic Factors in Adult Soft Tissue Sarcomas
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 4519
OP 4526
VO 25
IS 6C
A1 OTTAIANO, ALESSANDRO
A1 DE CHIARA, ANNA
A1 FAZIOLI, FLAVIO
A1 TALAMANCA, ANNARITA AIELLO
A1 MORI, STEFANO
A1 BOTTI, GERARDO
A1 MILANO, AMALIA
A1 APICE, GAETANO
YR 2005
UL http://ar.iiarjournals.org/content/25/6C/4519.abstract
AB Adult soft tissue sarcomas (STSs) are a rare group of highly heterogeneous neoplasms arising in different tissues. They are locally aggressive and can produce recurrence and distant metastasis. The most common metastatic sites are lung, lymph nodes, liver, bone and soft tissues. Staging for STSs has been based on some prognostic information: grade (low vs. intermediate/high grade), size (small vs. large tumors), depth of infiltration (superficial vs. deep neoplasms) and presence or not of distant metastasis. In the last 10 years, a plethora of new markers (proliferation markers and DNA alteration, P-gp, p53, TLS-CHOP, cyclins, survivin, TERT, PAX3-PAX7/FKHR, Syt-SSX1/2, VEGF, E-cadherin and beta-catenin, nm23, SKP-2, p27, CD40) has been studied with regard to their role in promoting progression (in a laboratory setting) and then determining prognosis and therapy (in a clinical setting). In the present survey, we focused on the role of new biological prognostic factors in STSs and also reported the quality of such studies with an ad hoc designed questionnaire. Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved